RECRUITINGOBSERVATIONAL
Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane
Real-time Monitoring of Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy: Propensity Score-matched Comparison Between oXiris and Polysulfone Membranes
About This Trial
The new adsorbing membrane for continuous renal replacement therapy (CRRT), oXiris, can reduce plasma cytokines and endotoxins in septic shock patients with severe acute kidney injury, compared with standard membranes. However, its hemodynamic stability or benefits have not been thoroughly evaluated although this is reasonable.
Who May Be Eligible (Plain English)
Who May Qualify:
- Aged ≥ 18 years
- Sepsis related acute kidney injury requiring continuous renal replacement therapy
Who Should NOT Join This Trial:
• No monitoring of blood pressure and ECG
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Aged ≥ 18 years
* Sepsis related acute kidney injury requiring continuous renal replacement therapy
Exclusion Criteria:
• No monitoring of blood pressure and ECG
Treatments Being Tested
DEVICE
oXiris membrane
Perform continuous renal replacement therapy with oXiris membrane
DEVICE
Polysulfone membrane
Perform continuous renal replacement therapy with polysulfone membrane
Locations (1)
Seoul National University Hospital
Seoul, South Korea